Diseases & Conditions market research reports by DelveInsight

• Genital Herpes - Market Insight, Epidemiology And Market Forecast - 2032

  Nov 01, 2022  |  Published by: DelveInsight  |  USD 9,500

  Genital Herpes - Market Insight, Epidemiology And Market Forecast - 2032 DelveInsight's ""Genital Herpes- Market Insight, Epidemiology and Market Forecast-2032"" report delivers an in-depth understanding of Genital Herpes, historical and forecasted epidemiology as well as the Genital Herpes trends i ... Read More

• Alzheimer’s Disease Diagnostic Market Insights, Competitive Landscape and, Market Forecast - 2027

  Nov 01, 2022  |  Published by: DelveInsight  |  USD 2,750

  Alzheimer’s Disease Diagnostic Market Insights, Competitive Landscape and, Market Forecast - 2027 ALZHEIMER’S DISEASE (AD) DIAGNOSTIC MARKET BY DIAGNOSTICS TYPE (BRAIN IMAGING [COMPUTED TOMOGRAPHY (CT), MAGNETIC RESONANCE IMAGING (MRI), POSITRON EMISSION TOMOGRAPHY (PET), AND OTHERS], GENETIC TESTIN ... Read More

• Chronic Hepatitis B Virus Infection - Pipeline Insight, 2022

  Nov 01, 2022  |  Published by: DelveInsight  |  USD 2,500

  Chronic Hepatitis B Virus Infection - Pipeline Insight, 2022 DelveInsight’s, “Chronic Hepatitis B Virus Infection - Pipeline Insight, 2022,” report provides comprehensive insights about 50+ companies and 55+ pipeline drugs in Chronic Hepatitis B Virus Infection pipeline landscape. It covers the pi ... Read More

• Rhinitis - Pipeline Insight, 2022

  Nov 01, 2022  |  Published by: DelveInsight  |  USD 2,000

  Rhinitis - Pipeline Insight, 2022 DelveInsight’s, “Rhinitis - Pipeline Insight, 2022,” report provides comprehensive insights about 35+ companies and 35+ pipeline drugs in Rhinitis pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also c ... Read More

• Peritoneal Cancer - Pipeline Insight, 2022

  Nov 01, 2022  |  Published by: DelveInsight  |  USD 2,500

  Peritoneal Cancer - Pipeline Insight, 2022 DelveInsight’s, “Peritoneal cancer – Pipeline Insight, 2022,” report provides comprehensive insights about 55+ companies and 55+ pipeline drugs in Peritoneal cancer pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical ... Read More

• Chronic Hepatitis Delta Virus (HDV) Infection - Pipeline Insight, 2022

  Nov 01, 2022  |  Published by: DelveInsight  |  USD 1,500

  Chronic Hepatitis Delta Virus (HDV) Infection - Pipeline Insight, 2022 DelveInsight’s, “Chronic Hepatitis Delta Virus (HDV) Infection - Pipeline Insight, 2022,” report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Chronic Hepatitis Delta Virus (HDV) Infection pipeline ... Read More

• Lyme Disease - Pipeline Insight, 2022

  Nov 01, 2022  |  Published by: DelveInsight  |  USD 1,250

  Lyme Disease - Pipeline Insight, 2022 DelveInsight’s, “Lyme Disease - Pipeline Insight, 2022,” report provides comprehensive insights about 7+ companies and 7+ pipeline drugs in Lyme Disease pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. ... Read More

• HER2 Positive Gastric Cancer - Pipeline Insight, 2022

  Nov 01, 2022  |  Published by: DelveInsight  |  USD 1,500

  HER2 Positive Gastric Cancer - Pipeline Insight, 2022 DelveInsight’s, “HER2 Positive Gastric Cancer - Pipeline Insight, 2022,” report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in HER2 Positive Gastric Cancer pipeline landscape. It covers the pipeline drug profiles, i ... Read More

• Chlamydia - Pipeline Insight, 2022

  Nov 01, 2022  |  Published by: DelveInsight  |  USD 1,250

  Chlamydia - Pipeline Insight, 2022 DelveInsight’s, “Chlamydia - Pipeline Insight, 2022,” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Chlamydia pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also ... Read More

• Marginal Zone Lymphoma - Pipeline Insight, 2022

  Nov 01, 2022  |  Published by: DelveInsight  |  USD 2,500

  Marginal Zone Lymphoma - Pipeline Insight, 2022 DelveInsight’s, “Marginal Zone Lymphoma - Pipeline Insight, 2022,” report provides comprehensive insights about 50+ companies and 50+ pipeline drugs in Marginal Zone Lymphoma pipeline landscape. It covers the pipeline drug profiles, including clinical ... Read More

• Adenoid Cystic Carcinoma - Pipeline Insight, 2022

  Nov 01, 2022  |  Published by: DelveInsight  |  USD 1,250

  Adenoid Cystic Carcinoma - Pipeline Insight, 2022 DelveInsight’s, “Adenoid Cystic Carcinoma- Pipeline Insight, 2022” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Adenoid Cystic Carcinoma pipeline landscape. It covers the pipeline drug profiles, including clinica ... Read More

• Testicular Cancer - Pipeline Insights, 2022

  Nov 01, 2022  |  Published by: DelveInsight  |  USD 1,250

  Testicular Cancer - Pipeline Insights, 2022 DelveInsight’s, “Testicular Cancer - Pipeline Insight, 2022,” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Testicular Cancer pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical ... Read More

• Plaque Psoriasis - Pipeline Insight, 2022

  Nov 01, 2022  |  Published by: DelveInsight  |  USD 2,500

  Plaque Psoriasis - Pipeline Insight, 2022 DelveInsight’s, “Plaque Psoriasis - Pipeline Insight, 2022,” report provides comprehensive insights about 75+ companies and 75+ pipeline drugs in Plaque Psoriasis pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical st ... Read More

• Obesity - Pipeline Insights, 2022

  Nov 01, 2022  |  Published by: DelveInsight  |  USD 3,000

  Obesity - Pipeline Insights, 2022 DelveInsight’s, “Obesity - Pipeline Insight, 2022,” report provides comprehensive insights about 100+ companies and 130+ pipeline drugs in Obesity pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also co ... Read More

• Head and Neck cancer - Pipeline Insight, 2022

  Nov 01, 2022  |  Published by: DelveInsight  |  USD 3,000

  Head and Neck cancer - Pipeline Insight, 2022 DelveInsight’s, “Head and Neck cancer - Pipeline Insight, 2022,” report provides comprehensive insights about 150+ companies and 150+ pipeline drugs in Head and Neck cancer pipeline landscape. It covers the pipeline drug profiles, including clinical and ... Read More

• Genital Herpes - Pipeline Insight, 2022

  Nov 01, 2022  |  Published by: DelveInsight  |  USD 2,000

  Genital Herpes - Pipeline Insight, 2022 DelveInsight’s, “Genital Herpes - Pipeline Insight, 2022,” report provides comprehensive insights about 26+ companies and 28+ pipeline drugs in Genital Herpes pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage p ... Read More

• Sexually Transmitted Diseases Diagnostics Market Insights, Competitive Landscape and, Market Forecast - 2027

  Nov 01, 2022  |  Published by: DelveInsight  |  USD 2,750

  Sexually Transmitted Diseases Diagnostics Market Insights, Competitive Landscape and, Market Forecast - 2027 SEXUALLY TRANSMITTED DISEASES (STD) DIAGNOSTICS BY TYPE OF DISEASE (CHLAMYDIA, GONORRHEA & SYPHILIS, HERPES SIMPLEX VIRUS, HUMAN PAPILLOMA VIRUS, HUMAN IMMUNODEFICIENCY VIRUS, AND OTHERS), BY ... Read More

• Cancer Immunotherapy Market Insights, Competitive Landscape and, Market Forecast - 2027

  Nov 01, 2022  |  Published by: DelveInsight  |  USD 2,750

  Cancer Immunotherapy Market Insights, Competitive Landscape and, Market Forecast - 2027 CANCER IMMUNOTHERAPY MARKET BY TYPE (MONOCLONAL ANTIBODIES, IMMUNOMODULATORS, CANCER VACCINES, CHECKPOINT INHIBITORS, AND OTHERS), BY INDICATION (LUNG CANCER, BREAST CANCER, PROSTATE CANCER, COLORECTAL CANCER, AN ... Read More

• Human papillomavirus 16-positive (HPV16+) cancers - Pipeline Insight, 2022

  Nov 01, 2022  |  Published by: DelveInsight  |  USD 1,500

  Human papillomavirus 16-positive (HPV16+) cancers - Pipeline Insight, 2022 DelveInsight’s, “Human papillomavirus 16-positive (HPV16+) cancers - Pipeline Insight, 2022,” report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Human papillomavirus 16-positive (HPV16+) canc ... Read More

• Primary Mediastinal Large B-Cell Lymphoma - Pipeline Insight, 2022

  Nov 01, 2022  |  Published by: DelveInsight  |  USD 2,000

  Primary Mediastinal Large B-Cell Lymphoma - Pipeline Insight, 2022 DelveInsight’s, Primary Mediastinal Large B-Cell Lymphoma - Pipeline Insight, 2022,” report provides comprehensive insights about 18+ companies and 20+ pipeline drugs in Primary Mediastinal Large B-Cell Lymphoma pipeline landscape. I ... Read More

• Diabetic Retinopathy - Pipeline Insight, 2022

  Nov 01, 2022  |  Published by: DelveInsight  |  USD 2,500

  Diabetic Retinopathy - Pipeline Insight, 2022 DelveInsight’s, “Diabetic Retinopathy – Pipeline Insight, 2022,” report provides comprehensive insights about 60+ companies and 60+ pipeline drugs in Diabetic Retinopathy pipeline landscape. It covers the pipeline drug profiles, including clinical and no ... Read More

• Cutaneous Lupus Erythematosus – Pipeline Insight, 2022

  Nov 01, 2022  |  Published by: DelveInsight  |  USD 1,500

  Cutaneous Lupus Erythematosus – Pipeline Insight, 2022 DelveInsight’s, “Cutaneous Lupus Erythematosus – Pipeline Insight, 2022,” report provides comprehensive insights about 10+ companies and 12+ pipeline drugs in Cutaneous Lupus Erythematosus pipeline landscape. It covers the pipeline drug profiles ... Read More

• Lung Adenocarcinoma - Pipeline Insight, 2022

  Nov 01, 2022  |  Published by: DelveInsight  |  USD 2,000

  Lung Adenocarcinoma - Pipeline Insight, 2022 DelveInsight’s, “Lung Adenocarcinoma - Pipeline Insight, 2022,” report provides comprehensive insights about 25+ companies and 25+ pipeline drugs in Lung Adenocarcinoma pipeline landscape. It covers the pipeline drug profiles, including clinical and noncl ... Read More

• Oncolytic Virus - Competitive Landscape, 2022

  Oct 01, 2022  |  Published by: DelveInsight  |  USD 3,950

  Oncolytic Virus - Competitive Landscape, 2022 DelveInsight’s, “Oncolytic Virus - Competitive landscape, 2022,” report provides comprehensive insights about 150+ companies and 175+ drugs in Oncolytic Virus Competitive landscape. It covers the therapeutics assessment by product type, stage, route of ... Read More

• COVID-19- Competitive Landscape, 2022

  Oct 01, 2022  |  Published by: DelveInsight  |  USD 4,950

  COVID-19- Competitive Landscape, 2022 DelveInsight’s, “COVID-19- Competitive landscape, 2022,” report provides comprehensive insights about 420+ companies and 520+ drugs in Covid-19 Competitive landscape. It covers the therapeutics assessment by product type, stage, route of administration, and mole ... Read More

< prev 17 18 19 20 21 22 23 24 25 26 next >